Cancer associated retinopathy

References

• Antel JP, Moumdjian R. Paraneoplastic syndromes: a role for the immune system. J Neurol 1989; 236: 1–3
   PubMedGoogle Scholar
• Naschitz JE, Abrahamson J, Yeshurun D. Clinical significance of paraneoplastic syndrome. Oncology 1989; 46: 40–44
   PubMedGoogle Scholar
• Greco FA, Oldham RK, Bunn PA. Small Cell Lung Cancer. Grune & Stratton, New York 1981
   Google Scholar
• Weiss W. Epidemiology of lung cancer. Comparative Respiratory Tract Carcinogenesis, H Reznik-Schuller. CRC Press, Inc, Boca Raton 1983; 1–17
   Google Scholar
• Weiss W. Small cell carcinoma of the lung: Epidemiology and etiology. Small Cell Lung Cancer, FA Greco, RK Oldham, PA Bunn. Grune & Stratton, New York 1981; 1–34
   Google Scholar
• Greco FA, Hainsworth J, Sismani A, Richardson RL, Hande KR, Oldham RK. Hormone production and paraneoplastic syndromes. Small Cell Lung Cancer, FA Greco, RK Oldham, PA Bunn. Grune & Stratton, New York 1981; 177–224
   Google Scholar
• Li WH. An ultrastructural classification of carcinomas of the lung. Chinese J Pathol 1992; 21(5)262–265
   PubMedGoogle Scholar
• Forster BB. Muller NL, Miller RR, Nelems B, Evans KG. Neuroendocrine carcinomas of the lung: clinical, radiologic, and pathologic correlation. Radiology 1989; 170(2)441–445
   PubMedGoogle Scholar
• Yalow RS. Big ACTH and bronchogenic carcinoma. Annu Rev Med 1979; 30: 241–248
   PubMedGoogle Scholar
• Havemann K, Gropp C, Scheuer A, Scherfe T, Gramse M. ACTH-like activity in immnune complexes of patients with oat-cell carcinoma of the lung. Br J Cancer 1979; 39: 43–50
   PubMedGoogle Scholar
• Yamada Y, Ito S, Miyashita M, et al. Clinical studies of 'big ACTH': its physico-chemical characteristics. Acta Endocrinol (Kbh) 1978; 89: 221–231
   PubMedGoogle Scholar
• Krieger DT, Choi HS, Anderson PJ. The characterization of the ACTH produced by a primary pituitary tumour in a patient with Cushing's disease. Clin Endocrinol (Oxford) 1976; 5: 455–472
   PubMedGoogle Scholar
• Yalow RS. Multiple forms of corticotropin (adrenocorticotropic hormone, ACTH) and their significance. Polypeptide Hormones: Molecular and Cellular Aspects. Ciba Found Symp No 41. Elsevier/Excerpta Medica/North-Holland, Amsterdam 1976; 159–181
   Google Scholar
• Ayvazian LF, Schneider B, Gewirtz G, Yalow RS. Ectopic production of big ACTH in carcinoma of the lung. Its clinical usefulness as a biologic marker. Am Rev Respir Dis 1975; 111: 279–287
   PubMed Web of Science ®Google Scholar
• Yalow RS, Berson SA. Characteristics of 'big ACTH' in human plasma and pituitary extracts. J Clin Endocrinol Metabol 1973; 36: 415–423
   PubMed Web of Science ®Google Scholar
• Jacobson DM, Thirkill CE, Tipping SJ. A clinical triad to diagnose paraneoplastic retinopathy. Ann Neurol 1990; 28: 162–167
   PubMed Web of Science ®Google Scholar
• Graus F, Rene R. Clinical and pathological advances on central nervous system paraneoplastic syndromes. Rev Neurol 1992; 148(6-7)496–501
   PubMedGoogle Scholar
• Anderson NE, Budde-Steffen C, Rosenblum MK, et al. Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. Medicine (Baltimore) 1988; 67: 100–109
   PubMed Web of Science ®Google Scholar
• Graus F, Cordon-Cardo C, Cho ES, Posner JB. Opsoclonus and oat cell carcinoma of the lung. Lack of evidence for anti-CNS antibodies. Lancet 1984; 1: 1479
   PubMed Web of Science ®Google Scholar
• Dropcho E, Payne R. Paraneoplastic opsoclonus myoclonus. Association with medullary thyroid carcinoma and review of the literature. Arch Neurol 1986; 43: 410–415
   PubMed Web of Science ®Google Scholar
• Anderson NE, Cunningham JM, Posner JB. Autoimmune pathogenesis of paraneoplastic neurological syndromes. Crit Rev Neurobiol 1987; 3: 245–299
   PubMedGoogle Scholar
• Sheinman BD, Gawler J. Opsoclonus and polymyoclonia complicating oat-cell carcinoma of the bronchus. Postgrad Med J 1982; 58: 704–705
   PubMed Web of Science ®Google Scholar
• Szabo A, Dalmau J, Manley G, et al. HuD a paraneoplastic encephalomyelitis antigen contains RNA binding domains and is homologous to Elav and Sex-Lethal. Cell 1991; 67: 325–333
   PubMedGoogle Scholar
• Luque FA, Furneaux HM, Ferziger R, et al. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 1991; 29: 241–251
   PubMed Web of Science ®Google Scholar
• Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu associated paraneoplastic encephalomyeli-tis/sensory neuropathy. A clinical study of 71 patients. Medicine 1992; 71(2)59–72
   PubMedGoogle Scholar
• Dalmau J, Furneaux HM, Cordon-Cardo C, Posner JB. The expression of the Hu antigen in normal and tumor tissues. Neurology 1991; 41: 159
   Google Scholar
• Graus F, Elkon KB, Cordon-Cardo C, Posner JB. Sensory neuronopathy and small cell lung cancer: antineuronal antibody that also reacts with the tumor. Am J Med 1986; 80: 45–52
   PubMed Web of Science ®Google Scholar
• Graus F, Elkon KB, Lloberes P, Ribalta T, Torres A, Ussetti P. Neuronal antinuclear antibody (anti-Hu) in paraneoplastic encephalomyelitis simulating acute polyneuritis. Acta Neurol Scand 1987; 75: 249–252
   PubMedGoogle Scholar
• Graus F, Ribalta T, Campo E, Monforte R, Urbano A, Rozman C. Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis. Neurology 1990; 40: 219–222
   PubMedGoogle Scholar
• Dalmau J, Furneaux HM, Gralla RJ, Kris MG, Posner JB. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer-a quantitative western blot analysis. Ann Neurol 1990; 27: 544–552
   PubMed Web of Science ®Google Scholar
• Furneaux HM, Rosenblum MK, Dalmau J, et al. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 1990; 322: 1844–1851
   PubMedGoogle Scholar
• Anderson NE, Rosenblum MK, Graus F, Wiley RG, Posner JB. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology 1988; 38: 1391–1398
   PubMed Web of Science ®Google Scholar
• Budde-Steffen C, Anderson NE, Rosenblum MK, et al. An antineuronal autoantibody in paraneoplastic opsoclonus. Ann Neurol 1988; 23: 528–531
   PubMedGoogle Scholar
• Budde-Steffen C, Anderson NE, Rosenblum MK, Posner JB. Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionpathy. Cancer Res 1988; 48: 430–434
   PubMed Web of Science ®Google Scholar
• Furneaux HM, Dropcho EJ, Barbut D, Chen YT, Rosenblum MK, Old LJ, Posner JB. Characterization of a cDNA encoding a 34-kDa Purkinje neuron protein recognized by sera from patients with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci USA 1989; 86: 2873–2877
   PubMedGoogle Scholar
• Dropcho EJ, Chen YT, Posner JB, Old LJ. Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci USA 1987; 84: 4552–4556
   PubMed Web of Science ®Google Scholar
• Anderson NE. Anti-neuronal autoantibodies and neurological paraneoplastic syndromes. Aust NZ J Med 1989; 19: 379–387
   PubMedGoogle Scholar
• Anderson NE, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol 1988; 24: 559–567
   PubMed Web of Science ®Google Scholar
• Newsom-Davis J. Lambert-Eaton myasthenic syndrome: a review. Monogr Allergy 1988; 25: 116–124
   PubMedGoogle Scholar
• Dorreen MS. Role of biological markers and probes in lung carcinomas. Bull Eur Physiopathol Respir 1986; 22: 137–146
   PubMedGoogle Scholar
• Lennon VA, Lambert EH. Autoantibodies bind solubilized calcium channel-omega-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome. Mayo Clin Proc 1989; 64: 1498–1504
   PubMed Web of Science ®Google Scholar
• Brain L, Wilkinson M. Subacute cerebellar degeneration associated with neoplasms. Brain 1965; 88: 465–478
   PubMed Web of Science ®Google Scholar
• Tetu B, Ro JY, Ayala AG, Ordonez NG, Logothetis CJ, von Eschenbach AC. Small cell carcinoma of prostate associated with myasthenic (Eaton-Lambert) syndrome. Urology 1989; 33: 148–152
   PubMed Web of Science ®Google Scholar
• de la Monte SM, Hutchins GM, Moore GW. Paraneoplastic syndromes and constitutional symptoms in prediction of metastatic behavior of small cell carcinoma of the lung. Am J Med 1984; 77: 851–857
   PubMedGoogle Scholar
• Greenlee JE, Brashear HR. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol 1983; 14: 609–613
   PubMed Web of Science ®Google Scholar
• Kornguth SE. Neuronal proteins and paraneoplastic syndromes. N Engl J Med 1989; 321: 1607–1608
   PubMedGoogle Scholar
• Posner JB, Furneaux HM. Paraneoplastic syndromes. Immunologic Mechanisms in Neurologic and Psychiatric Disease, BH Waksman. Raven Press, Ltd, New York, NY 1990; 187–219
   Google Scholar
• Graus F, Ferrer I. Analysis of a neuronal antigen (Hu) expression in the developing rat brain detected by autoantibodies from patients with paraneoplastic encephalomyelitis. Neurosci Lett 1990; 112: 14–18
   PubMedGoogle Scholar
• Graus F, Elkon KB, Cordon-Cardo C, Posner JB. Pure sensory neuropathy. Restriction of the Hu antibody to the sensory neuropathy associated with small cell carcinoma of the lung. Neurologia 1986; 1: 11–15
   PubMedGoogle Scholar
• Rodriguez M, Truh LI, O'Neill BP, Lennon VA. Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells. Neurology 1988; 38: 1380–1386
   PubMedGoogle Scholar
• Gorny MK, Lawniczak M, Jenek R, Slowik-Gabryelska A, Kaczmarek E, Zeromski J. Alloantibodies, autoantibodies, and immune complexes in patients with lung cancer. Lung 1988; 166: 97–105
   PubMedGoogle Scholar
• Hetzel DJ, Stanhope CR, O'Neill BP, Lennon VA. Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume. Mayo Clin Proc 1990; 65: 1558–1563
   PubMed Web of Science ®Google Scholar
• Lennon VA. Anti-Purkinje cell cytoplasmic and neuronal nuclear antibodies aid diagnosis of paraneoplastic autoimmune neurological disorders. Neurol Neurosurg Psychiat 1989; 52: 1438–1439
   PubMedGoogle Scholar
• Thirkill CE, Tail RC, Tyler NK, Roth AM, Keltner JL. Intraperitoneal cultivation of small-cell carcinoma induces expression of the retinal cancer-associated retinopathy antigen. Arch Ophthalmol 1993; 111: 974–978
   PubMedGoogle Scholar
• Thirkill CE, Tail RC, Tyler NK, Roth AM, Keltner JL. The cancer connection: an antigen immunologically related to the retinal CAR antigen is expressed in small cell carcinoma of the lung. Proc Third Int Symp on Uveitis 1993; 133–135
   Google Scholar
• Graus F, Segurado OG, Tolosa E. Selective concentration of anti-Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration. Acta Neurol Scand 1988; 78: 210–213
   PubMedGoogle Scholar
• Graus F, Vega F, Delattre JI, et al. Effect of plasmapheresis in paraneoplastic encephalomyelitis and paraneoplastic cerebellar degeneration with circulating autoantibodies. Neurology 1991; 41: 238
   Google Scholar
• Sutton GP, Siemers E, Stehman FB, Ehrlich CE. Eaton-Lambert syndrome as a harbinger of recurrent small-cell carcinoma of the cervix with improvement after combination chemotherapy. Obstet Gynecol 1988; 72: 516–518
   PubMedGoogle Scholar
• Graus F, Abos J, Roquer J, Mazzara R, Pereira A. Effect of plasmapheresis on serum and CSF autoantibody levels in CNS paraneoplastic syndromes. Neurology 1990; 40: 1621–1623
   PubMed Web of Science ®Google Scholar
• Weissman DE, Gottschall JL. Complete remission of paraneoplastic sensorimotor neuropathy: a case associated with small-cell lung cancer responsive to chemotherapy, plasma exchange, and radiotherapy. J Clin Apheresis 1989; 5: 3–6
   PubMedGoogle Scholar
• Chalk CH, Murray NM, Newsom-Davis J, O'Neill JH, Spiro SG. Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma. Neurology 1990; 40: 1552–1556
   PubMed Web of Science ®Google Scholar
• Kearsley JH, Johnson P, Halmagyi GM. Paraneoplastic cerebellar disease. Remission with excision of the primary tumor. Arch Neurol 1985; 42: 1208–1210
   PubMedGoogle Scholar
• Richman DP, Fairclough RH, Xu Q, Agius MA. Noninflammatory immune mechanisms in diseases of the nervous system. Ass Res Nerv Ment Dis 1990; 68: 55–65
   PubMedGoogle Scholar
• Matsui M, Mori KJ, Saida T. Cellular immunoregulatory mechanisms in the central nervous system. Ann Neurol 1990; 27(6)647–651
   PubMedGoogle Scholar
• Couser WG. Mediation of immune glomerular injury. J Am Soc Neph 1990; 1(1)13–29
   PubMedGoogle Scholar
• Couser WG. Pathogenesis of glomerulonephritis. Kidney Int Suppl 1993; 42: 19–26
   Google Scholar
• Drachman DB. How to recognize an antibody-mediated autoimmune disease: Criteria. Immunologic Mechanisms in Neurologic and Psychiatric Disease, BH Waksman. Raven Press, New York 1990; 183–186
   Google Scholar
• Liu Z, Diaz LA, Troy JL, Taylor AF, Emery DJ, Fairley JA, Giudice GJ. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 1993; 92(5)2480–2488
   PubMed Web of Science ®Google Scholar
• Lang B, Newsom-Davis J, Prior C, Wray D. Antibodies to motor nerve terminals: An electrophysiological study of a human myasthenic syndrome transferred to mouse. J Physiol 1983; 344: 335–345
   PubMed Web of Science ®Google Scholar
• Kim YI. Passively transferred Lambert-Eaton syndrome in mice receiving purified IgG. Muscle Nerve 1986; 9: 523–530
   PubMedGoogle Scholar
• Anhalt GJ, Kim S, Stanley JR, et al. Paraneoplastic pemphigus-An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990; 323: 1729–1735
   PubMed Web of Science ®Google Scholar
• Ahmed I. Antipurkinje cell antibodies in cerebellar degeneration. Kansas Med 1989; 90: 279–281
   PubMedGoogle Scholar
• Furneaux HF, Reich L, Posner JB. Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 1990; 40: 1085–1091
   PubMed Web of Science ®Google Scholar
• Newsom-Davis J. Diseases of the myoneural junction. Research Publications-Ass Res Nerv Ment Dis 1990; 68: 233–240
   PubMedGoogle Scholar
• Sakai K, Mitchell DJ, Tsukamoto T, Steinman L. Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration. Ann Neurol 1990; 28: 692–698
   PubMedGoogle Scholar
• Witebsky E. Concept of autoimmune disease. Ann NY Acad Sci 1966; 135: 443–450
   PubMed Web of Science ®Google Scholar
• McFarland HF. Immunology of multiple sclerosis. Ann NY Acad Sci 1988; 540: 99–105
   PubMedGoogle Scholar
• Rodien P, Madek AM, Morel Y, Stefanutti A, Bornet H, Orgiazzi J. Assessment of antibody dependent cell cytotoxicity in autoimmune thyroid disease using porcine thyroid cells. Autoimmunity 1992; 13(3)177–185
   PubMed Web of Science ®Google Scholar
• Davies KA. Complement. Baillières Clin Haematol 1991; 4: 927–955
   PubMedGoogle Scholar
• Nerup J, Mandrup-Poulsen T, Molvig J, Helqvist S, Wogensen L, Egeberg J. Mechanisms of pancreatic beta-cell destruction in type I diabetes. Diabetes Care 1988; 11: 16–23
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Egeberg J, Nerup J, Bendtzen K, Nielsen JH, Dinarello CA. Ultrastructural studies of time-course and cellular specificity of interleukin-I mediated islet cytotoxicity. Acta Pathol Microbiol Immunol Scand [C] 1987; 95: 55–63
   PubMedGoogle Scholar
• Kulkarni PS, Mancino M. Studies on intraocular inflammation produced by intravitreal human interleukins in rabbits. Exp Eye Res 1993; 56: 275–279
   PubMedGoogle Scholar
• Hoekzema R, Murray PI, Kijlstra A. Cytokines and intraocular inflammation. Curr Eye Res 1990; 9: 207–211, Suppl
   PubMed Web of Science ®Google Scholar
• Buchanan TA, Gardiner TA, Archer DB. An ultrastructural study of retinal photoreceptor degeneration associated with bronchial carcinoma. Am J Ophthalmol 1984; 97: 277–287
   PubMed Web of Science ®Google Scholar
• Fretland DJ. Potential role of prostaglandins and leukotrienes in multiple sclerosis and experimental allergic encephalomyelitis. Prostaglandins Leukot Essent Fatty Acids 1992; 45: 249–257
   PubMedGoogle Scholar
• Handelsman DJ, Dong Q. Hypothalamo-pituitary gonadal axis in chronic renal failure. Endo Metab Clin N Am 1993; 22(1)145–161
   PubMedGoogle Scholar
• Thirkill CE, Tyler NK, Roth AM, Keltner JL. A comparison of antibody reaction with retina and cancer antigens in ten patients with Cancer-Associated Retinopathy. Arch Ophthalmol 1993; 111: 931–937
   PubMedGoogle Scholar
• Lafeuillade A, Quilichini R, Chiozza R, Pellegrino P, Thirkill CE. Paraneoplastic retinopathy (CAR syndrome) revealing prostatic cancer. Presse Méd 1993; 22(1)35
   PubMedGoogle Scholar
• Keltner JL, Roth AM, Chang RS. Photoreceptor degeneration. Possible autoimmune disorder. Arch Ophthalmol 1983; 101: 564–569
   PubMed Web of Science ®Google Scholar
• Thirkill CE, Roth AM, Keltner JL. Cancer-associated retinopathy. Arch Ophthalmol 1987; 105: 372–375
   PubMedGoogle Scholar
• Katz JL, Valsamis MP, Jampel RS. Ocular signs in diffuse carcinomatous meningitis. Am J Ophthalmol 1961; 52: 681–690
   PubMedGoogle Scholar
• Susac JO, Lawton-Smith J, O'Powell JO. Carcinomatous optic neuropathy. Am J Ophthalmol 1973; 76: 672–679
   PubMedGoogle Scholar
• Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 1976; 81: 606–613
   PubMed Web of Science ®Google Scholar
• Kornguth SE, Klein R, Appen R, Choate J. Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung. Cancer 1982; 50: 1289–1293
   PubMed Web of Science ®Google Scholar
• Kornguth SE, Kalinke T, Grunwald GB, Schutta H, Dahl D. Anti-neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome. Cancer Res 1986; 46: 2588–2595
   PubMed Web of Science ®Google Scholar
• Adamus G. Guy J, Schmeid JL, Arendt A, Hargrave PA. Role of anti-recoverin autoantibodies in Cancer-Associated Retinopathy. Invest Ophthalmol Vis Sci 1993; 34: 2626–2633
   PubMed Web of Science ®Google Scholar
• Klingele TG, Burde RM, Rappazzo JA, Isserman MJ, Burgess D, Kantor O. Paraneoplastic retinopathy. J Clin Neuro Ophthalmol 1984; 4: 239–245
   Google Scholar
• Grunwald GB, Klein R, Simmonds MA, Kornguth SE. Autoimmune basis for visual paraneoplastic syndrome in patients with small-cell lung carcinoma. Lancet 1985; 1: 658–661
   PubMed Web of Science ®Google Scholar
• Grunwald GB, Kornguth SE, Towfighi J, et al. Autoimmune basis for visual paraneoplastic syndrome in patients with small cell lung carcinoma. Retinal immune deposits and ablation of retinal ganglion cells. Cancer 1987; 60: 780–786
   PubMedGoogle Scholar
• Thirkill CE, Tait RC, Tyler NK, Roth AM, Keltner JL. The Cancer Connection: An antigen immunologically related to the retinal CAR antigen is expressed in small cell carcinoma of the lung, JP Dernouchamps. Kugler Publications, Amsterdam/New York 1993; 133–135
   Google Scholar
• Polans AS, Burton MD, Halet TL, Crabb JW, Palczewski K. Recoverin but not visinin is an autoantigen in the human retina identified with a Cancer-Associated Retinopathy. Invest Ophthalmol Vis Sci 1993; 34: 81–90
   PubMedGoogle Scholar
• Milam AH, Dacey DM, Dizhoor AM. Recoverin immunoreactivity in mammalian cone bipolar cells. Vis Neurosci 1993; 10: 1–12
   PubMed Web of Science ®Google Scholar
• Takamatsu K, Uyemura K. Identification of recoverin-like immunoreactivity in mouse brain. Brain Res 1992; 571: 350–353
   PubMedGoogle Scholar
• Takamatsu K, Kitamura K, Noguchi T. Isolation and characterization of recoverin-like Ca(2+)-binding protein from rat brain. Biochem Biophys Res Commun 1992; 183: 245–251
   PubMedGoogle Scholar
• Cahill GM, Grace MS, Besharse JC. Rhythmic regulation of retinal melatonin: metabolic pathways, neurochemical mechanisms and ocular circadian clock. Cell Mol Neurol 1991; 11(5)529–560
   PubMedGoogle Scholar
• Milam AH, Saari JC, Jacobson SG. Lubinski WP, Feun LG, Alexander KR. Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci 1993; 34: 91–100
   PubMed Web of Science ®Google Scholar
• Wiechmann AF. Localization of hydroxyindole-O-methyltransferase in retina: A re-evaluation. Exp Eye Res 1993; 57: 379–380
   PubMedGoogle Scholar
• Wiechmann AF, Holly field JG. Immunocytochemistry of retinitis pigmentosa retinas: localization of HIOMT immunoreactivity in surviving photoreceptor cells. Prog Clin Biol Res 1987; 247: 69–77
   PubMedGoogle Scholar
• Milam AH, Dacey DM, Dizhoor AM. Recoverin immunoreactivity in mammalian cone bipolar cells. Vis Neurosci 1993; 10: 1–12
   PubMed Web of Science ®Google Scholar
• Wiechmann AF, O'Steen WK. Melatonin increases photoreceptor susceptibility to light-induced damage. IOVS 1992; 33(6)1894–1902
   PubMedGoogle Scholar
• Hansson I, Holmdahl R, Matteson R. The pineal hormone melatonin exaggerates development of collagen-induced arthritis in mice. J Neuro-immunol 1992; 39(1-2)23–30
   PubMed Web of Science ®Google Scholar
• Hansson I, Holmdahl R, Matteson R. Constant darkness enhances autoimmunity to type 11 collagen and exaggerates development of collagen-induced arthritis in DBA/i mice. J Neuroimmunol 1990; 27(1)79–84
   PubMedGoogle Scholar
• Kumar M, Gupta RM, Nema HV. Role of autoimmunity in retinitis pigmentosa. Ann Ophthalmol 1983; 15: 838–840
   PubMedGoogle Scholar
• Newsome DA, Quinn TC, Hess AD, Pitha-Rowe PM. Cellular immune status in retinitis pigmentosa. Ophthalmology 1988; 95: 1696–1703
   PubMed Web of Science ®Google Scholar
• Thirkill CE, Roth AM, Takemoto DJ, Tyler NK, Keltner JL. Antibody indications of secondary and superimposed retinal hypersensitivity in retinitis pigmentosa. Am J Ophthalmol 1991; 112: 132–137
   PubMedGoogle Scholar
• Foti D, Russo D, Costante G, Filetti S. The biological activity of bovine and human thyrotropin is differently affected by trypsin treatment of human thyroid cells: thyroid-stimulating antibody is related to human thyrotropin. J Clin Endocrin Metabol 1991; 73(4)710–716
   PubMedGoogle Scholar
• Thirkill CE, Tait RC, Tyler NK, Roth AM, Keltner JL. The Cancer-Associated Retinopathy is a Recoverin-like protein. Invest Ophthalmol Vis Sci 1992; 331: 2768–2772
   Google Scholar
• Ray S, Zozulya S, Niemi GA, et al. Cloning, expression, and crystallization of recoverin, a calcium sensor in vision. Proc Natl Acad Sci USA 1992; 89: 5705–5709
   PubMedGoogle Scholar
• Stryer L. Visual excitation and recovery. J Biol Chem 1991; 266: 10711–10714
   PubMed Web of Science ®Google Scholar
• Wiechmann AF, Hammarback JA. Molecular cloning and nucleotide sequence of a cDNA encoding recoverin from human retina. Exp Eye Res 1993; 56: 463–470
   PubMed Web of Science ®Google Scholar
• Murakami A, Yajima T, Inana G. Isolation of human retinal genes: recoverin cDNA and gene. Biochem Biophys Res Commun 1992; 187: 234–244
   PubMedGoogle Scholar
• Polans AS, Buczylko J, Crabb J, Palczewski K. A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy. J Cell Biol 1991; 112: 981–989
   PubMedGoogle Scholar
• Dizhoor AM, Ericsson LH, Johnson RS, et al. The NH2 terminus of retinal recoverin is acylated by a small family of fatty acids. J Biol Chem 1992; 267: 16033–16036
   PubMed Web of Science ®Google Scholar
• McGinnis JF, Stepanik PL, Baehr W, Subbaraya I, Lerious V. Cloning and sequencing of the 23 kDa mouse photoreceptor cell-specific protein. FEBS Lett 1992; 302: 172–176
   PubMed Web of Science ®Google Scholar
• Hurley JB, Dizhoor AM, Ray S, Stryer L. Recoverin's role: Conclusion withdrawn. Science 1993; 260: 740
   PubMedGoogle Scholar
• McGinnis JF, Lerious V, Paznik J, Elliott RW. Chromosomal assignment of the recoverin gene and cancer-associated retinopathy. Mam Gen 1993; 4: 43–45
   PubMedGoogle Scholar
• Amberger J, Steinberg J. Human genetic disorders. J NIH Res 1993; 5: 123–152
   Google Scholar
• McKusick VA. Mendelian Inheritance of Man10th edn. Johns Hopkins Univ Press, Baltimore 1992
   Google Scholar
• Fukunaga H, Engel AG, Lang B, Newsom Davis J, Vincent A. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl Acad Sci USA 1983; 80: 7636–7640
   PubMedGoogle Scholar
• Paone JF, Jeyasingham K. Remission of cerebellar dysfunction after pneumonectomy for bronchogenic carcinoma. N Engl J Med 1980; 302: 156
   PubMed Web of Science ®Google Scholar
• Gery I, Chanaud NP, Anglade E. Recoverin is highly uveitogenic in Lewis rats. IOVS 1994, in press
   PubMedGoogle Scholar
• Keltner JL, Thirkill CE, Tyler NK, Roth AM. Management and monitoring of cancer associated retinopathy (CAR). Arch Ophthalmol 1992; 110: 48–53
   PubMedGoogle Scholar
• Papazian O. Transient neonatal myasthenia gravis. J Child Neurol 1992; 7(2)135–141
   PubMedGoogle Scholar
• Brashear HR, Caccamo DV, Heck A, Keeney PM. Localization of antibody in the central nervous system of a patient with paraneoplastic encephalomyeloneuritis. Neurology 1991; 41: 1583–1587
   PubMedGoogle Scholar
• Christian CL, Elkon KB. Autoantibodies to intracellular proteins. Clinical and biologic significance. Am J Med 1986; 80: 53–61
   PubMedGoogle Scholar
• Thirkill CE, FitzGerald P, Sergott RC, Roth AM, Tyler NK, Keltner JL. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. N Engl J Med 1989; 321: 1589–1594
   PubMed Web of Science ®Google Scholar
• Newsome DA, Nussenblatt RB. Retinal S antigen reactivity in patients with retinitis pigmentosa and Usher's syndrome. Retina 1984; 4: 195–199
   PubMed Web of Science ®Google Scholar
• Yamaki K, Takahashi Y, Sakuragi S, Matsubara K. Molecular cloning of the S-antigen cDNA from bovine retina. Biochem Biophys Res Commun 1987; 142: 904–910
   PubMed Web of Science ®Google Scholar
• Dua HS, Lee RH, Lolley RN, et al. Induction of experimental autoimmune uveitis by the retinal photoreceptor cell protein, phosducin. Exp Eye Res 1992; 11: 107–111, suppl
   Google Scholar
• Heckenlively JR, Solish AM, Chant SM, Meyers-Elliott RH. Autoimmunity in hereditary retinal degenerations. II. Clinical studies: antiretinal antibodies and fluorescein angiogram findings. Br J Ophthalmol 1985; 69: 758–764
   PubMed Web of Science ®Google Scholar
• Heckenlively JR. The diagnosis and classification of retinitis pigmentosa. Retinitis Pigmentosa, JR Heckenlively. JB Lippincott, Philadelphia 1988; 6–24
   Google Scholar
• Petty RE, Johnston W, McCormick AQ, Hunt DW, Rootman J, Rollins DF. Uveitis and arthritis induced by adjuvant. Clinical, immunologic and histologic characteristics. J Rheumatol 1989; 16(4)499–505
   PubMedGoogle Scholar
• Matsui Y, Mehta MC, Katsumi O, Brodie SE, Hirose T. Electrophysiological findings in paraneoplastic retinopathy. Graefes Arch Clin Exp Ophthalmol 1992; 230(4)324–328
   PubMedGoogle Scholar
• Rizzo JF, Gittinger JW. Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome. Ophthalmology 1992; 99: 1286–1295
   PubMed Web of Science ®Google Scholar
• Thirkill CE, Roth AM, Keltner JL. Paraneoplastic retinopathy syndrome. Ophthalmology 1993; 100(2)147
   PubMedGoogle Scholar
• Thirkill CE, Keltner JL, Tyler NK, Roth AM. Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy. Arch Ophthalmol 1993; 111: 931–937
   PubMedGoogle Scholar
• Griffin JD, Gamick MB. Eye toxicity of cancer chemotherapy: a review of the literature. Cancer 1981; 48: 1539–1549
   PubMed Web of Science ®Google Scholar
• Imperia PS, Lazarus HM, Lass JH. Ocular complications of systemic cancer chemotherapy. Surv Ophthalmol 1989; 34: 209–230
   PubMedGoogle Scholar
• Kaplan RS, Wiernik PH. Neurotoxicity of antineoplastic drugs. Sem Oncol 1982; 9: 103–130
   PubMed Web of Science ®Google Scholar
• Loewenstein A, Zemel E, Lazar M, Perlman I. Drug-induced retinal toxicity in albino rabbits: The effects of Imipenem and Aztreonam. Invest Ophthalmol Vis Sci 1993; 34: 3466–3476
   PubMed Web of Science ®Google Scholar
• Pavlidis NA, Petris C, Briassoulis E, Klouvas G, Psilas C, Rempapis J, Petroutsos G. Clear evidence that long-term, low-dose, tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients. Cancer 1992; 69(12)2961–2964
   PubMedGoogle Scholar
• Sergott RC, Brown MJ, Silberberg DH, Lisak RP. Antigalactocerebroside serum demyelinates optic nerve in vivo. Neurol Sci 1984; 64: 297–303
   Google Scholar
• Anderson NE. Paraneoplastic optic neuritis and external ophthalmoplegia. Aust NZ J Med 1987; 17: 539
   PubMedGoogle Scholar
• Boghen DR, Sebag M, Michaud J. Paraneoplastic optic neuritis and encephalomyelitis. Arch Neurol 1988; 45: 353–356
   PubMedGoogle Scholar
• Pillay N, Gilbert JJ, Ebers GC, Brown JD. Internuclear ophthalmoplegia and 'optic neuritis': Paraneoplastic effects of bronchial carcinoma. Neurology 1984; 34: 788–791
   PubMed Web of Science ®Google Scholar
• Rudge P. Optic neuritis as a complication of carcinoma of the breast. Proc Roy Soc Med 1973; 66: 1106–1107
   PubMedGoogle Scholar
• Kiers L, Altermatt HJ, Lennon VA. Paraneoplastic anti-neuronal nuclear IgG autoantibodies (Type I) localize antigen in small cell lung carcinoma. Mayo Clin Proc 1991; 66: 1209–1216
   PubMedGoogle Scholar
• Sergott RC, Brown MJ, Polenta RM, Lisak RP, Silberberg DH. Optic nerve demyelination induced by human serum: patients with multiple sclerosis or optic neuritis and normal subjects. Neurology 1985; 35: 1438–1442
   PubMedGoogle Scholar
• Malinowski SM, Pulido JS, Folk JC. Long-term visual outcome and complications associated with pars planitis. Ophthalmology 1993; 100(6)818–824
   PubMed Web of Science ®Google Scholar
• Waterston JA, Gilligan BS. Paraneoplastic optic neuritis and external ophthalmoplegia. Aust NZ J Med 1986; 16: 703–704
   PubMedGoogle Scholar
• Alexander KR, Fishman GA, Peachey NS, Marchese AL, Tso MO. 'On' response defect in paraneoplastic night blindness with cutaneous malignant melanoma. Invest Ophthalmol Vis Sci 1992; 33: 477–483
   PubMed Web of Science ®Google Scholar
• Berson EL, Lessell S. Paraneoplastic night blindness with malignant melanoma. Am J Ophthalmol 1988; 106: 307–311
   PubMed Web of Science ®Google Scholar
• Weinstein J, Bresnick G, Kornguth SE. Paraneoplastic retinopathy associated with anti-retinal bipolar cell antibodies in cutaneous malignant melanoma. Ophthalmology 1994, In press
   PubMedGoogle Scholar
• Broekhuyse RM, Kuhlmann ED, Winkens HJ. Experimental autoimmune anterior uveitis (EAAU). Induction by immunization with purified uveal and skin melanins. Exp Eye Res 1993; 56(5)575–583
   PubMed Web of Science ®Google Scholar
• Cocconi G, Ceci G, Juvarra G, et al. Successful treatment of subacute cerebellar degeneration in ovarian carcinoma with plasmapheresis. A case report. Cancer 1985; 56: 2318–2320
   PubMed Web of Science ®Google Scholar
• Bashir R, Hochberg F. Paraneoplastic neurological syndromes. Cancer Invest 1988; 6: 117–118
   PubMed Web of Science ®Google Scholar
• Singh VK, Kalra HK, Yamaki K, Shinohara T. Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveito-pathogenic S-antigen fragment or a cross-reactive homologous peptide. Cellular Immunol 1992; 139: 81–90
   PubMed Web of Science ®Google Scholar
• Dick AD, Cheng YF, McKinnon A, Liversidge J, Forrester JV. Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. Br J Ophthalmol 1993; 77(3)171–175
   PubMedGoogle Scholar
• Nussenblatt RB, Caspi RR, Mahdi R, Chan CC, Roberge F, Lider O, Weiner HL. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol 1990; 144(5)1689–1695
   PubMedGoogle Scholar
• Thurau SR, Chan CC, Suh E, Nussenblatt RB. Induction of oral tolerance to S-antigen induced in experimental autoimmune uveitis by a uveitogenic 2omer peptide. J Autoimmunity 1991; 4(3)507–516
   PubMedGoogle Scholar
• Gregerson DS, Obritsch WF, Donoso LA. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J Immunol 1993; 151(10)5751–5761
   PubMed Web of Science ®Google Scholar
• Wang ZY, Qiac J, Link H. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor. J Neuroimmunol 1993; 44(2)209–214
   PubMed Web of Science ®Google Scholar
• Donoso LA, Gregerson DS, Smith L, et al. S-antigen: preparation and characterization of site-specific monoclonal antibodies. Curr Eye Res 1990; 9: 343–355
   PubMed Web of Science ®Google Scholar
• Donoso LA, Rodrigues M, Vrabec TR, Sery TW, Fong SL. IRBP: preparation and characterization of site-specific monoclonal antibodies. Curr Eye Res 1990; 9: 357–362
   PubMed Web of Science ®Google Scholar
• Hodges RS, Heaton RJ, Parker JM, Molday L, Molday RS. Antigen-antibody interaction. Synthetic peptides define linear antigenic determinants recognized by monoclonal antibodies directed to the cytoplasmic carboxyl terminus of rhodopsin. J Biol Chem 1988; 263: 11768–11775
   PubMed Web of Science ®Google Scholar
• Jerne NK. Idiotypic network and other preconceived ideas. Immunol Rev 1984; 79: 5–24
   PubMed Web of Science ®Google Scholar
• Benoit P, Boucheix C. Manipulation of the immune response by monoclonal antibodies in autoimmune pathology. Curr Eye Res 1990; 9: 201–205, suppl
   PubMed Web of Science ®Google Scholar
• de Kozak Y, Steimer RH, Mirshahi M, Frank RW, Smet M, Faure JP. Humoral immune response against the S-antigen/TNF alpha common epitope in rat EAU suppressed by the monoclonal antibody S2D2. Curr Eye Res 1992; 11: 119–127, suppl
   PubMed Web of Science ®Google Scholar
• de Kozak Y, Mirshani M. Experimental autoimmune uveoretinitis: Idiotypic regulation and disease suppression. Int Ophthalmol 1990; 14(1)43–56
   PubMedGoogle Scholar
• de Kozak Y. Regulation of retinal autoimmunity via the idiotypic network. Curr Eye Res 1990; 9: 193–200, suppl
   PubMed Web of Science ®Google Scholar
• Stull SJ, Kyriakos M, Sharp GC, Bickel JT, Braley-Mullen H. Effects of anti-I-A and anti-I-E monoclonal antibodies on the induction and expression of experimental autoimmune thyroiditis in mice. Autoimmunity 1990; 6(1-2)23–36
   PubMed Web of Science ®Google Scholar
• Roubaty C. Bedin C, Charreire J. Prevention of experimental autoimmune thyroiditis through the antiidiotype network. J Immunol 1990; 144(6)2167–2172
   PubMedGoogle Scholar
• Nydeggara U. Old and current aspects of intravenous immunoglobulin therapy. J Suisse Mèd 1994; 124(1-2)5–25
   Google Scholar
• Lattuada D, Mazzei M, Meazza R, Nicolin A. Therapeutic implications of antisense oligonucleotides. Int J Clin Lab Res 1992; 21(4)296–299
   PubMedGoogle Scholar